Prognosis
Moderna Says U.S. to Buy 100 Million More Vaccine Doses
- Government still has option to buy 300 million more doses
- $1.65 billion pact follows concern over potential shortfall
This article is for subscribers only.
Moderna Inc. said the U.S. government exercised its option to buy 100 million additional doses of the company’s coronavirus vaccine candidate, doubling the amount of the shot it initially committed to purchase and easing concern that the U.S. could be left with a vaccine shortfall.
Moderna said Friday that the order, worth $1.65 billion, would be delivered during the second quarter of 2021. The Cambridge, Massachusetts-based drugmaker will be able to provide a continuous supply of vaccine doses through the end of June, according to the U.S. government.